Related Experiment Video For Adenocarcinoma
Updated: May 10, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
[Prostate cancer in the biopsy : Diagnostic criteria, mimickers/pitfalls, and subtypes]
Glen Kristiansen1, Marit Bernhardt2
1Institut für Pathologie, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland. glen.kristiansen@ukbonn.de.
Abstract:
Despite advances in imaging diagnostics, the histological confirmation of suspected carcinoma through prostate core needle biopsy remains essential for therapy planning. Diagnosis is based on established morphological criteria such as architectural disturbances, cellular atypia, and the loss of the basal cell layer. In addition to the most common acinar prostate carcinoma, various subtypes and rare histological patterns exist, which must be differentiated from benign mimickers. Immunohistochemical methods support diagnostic accuracy but should be carefully interpreted in the context of morphology. Tumor extent in core biopsy specimens should preferably be reported in millimeters. Diagnostic uncertainties can be coded as atypical small acinar proliferation (ASAP) or atypical intraductal proliferation (AIP) to facilitate appropriate clinical interpretation.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
05:49Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019